Pharmacists in Piqua, Ohio


12 Pharmacists found in Piqua
female pharmacist

Catherine Kauffman


Pharmacist
115 N College St, Piqua, OH 45356
937-773-3784    

female pharmacist

Dana Lynn Lautzenheiser, PHARMD


Pharmacist
1508 Covington Ave, Piqua, OH 45356
937-615-7020     937-615-7055

male pharmacist

Mr. Frederick John Labs, RPH


Pharmacist
1510 Covington Ave, Piqua, OH 45356
937-615-7020     937-615-7055



female pharmacist

Dr. Holly Jensvold, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1510 Covington Ave, Piqua, OH 45356
937-615-7020     937-615-7055

male pharmacist

Jeffrey Alan Hogrefe, RPH


Pharmacist - Pharmacotherapy
649 W High St, Piqua, OH 45356
937-773-1778     937-773-0643

female pharmacist

Dr. Jessica Osterloh, PHARMD


Pharmacist
1510 Covington Ave, Piqua, OH 45356
937-615-7020     937-615-7055

male pharmacist

Dr. Justin Coby, PHARM.D.


Pharmacist
115 N College St, Piqua, OH 45356
937-773-3784    

female pharmacist

Laura V Eilerman, PHARMD, R.PH


Pharmacist
1300 E Ash St, Piqua, OH 45356
937-615-9968    

female pharmacist

Mrs. Michele Marie Oaks, RPH, CDE


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1510 Covington Ave, Piqua, OH 45356
937-381-8247     937-615-7055

male pharmacist

Nicholas Patrick Franks, RPH


Pharmacist
1300 E Ash St, Piqua, OH 45356
937-615-9968    

female pharmacist

Dr. Stephanie Lee Clack, PHARMD, RPH


Pharmacist
1300 E Ash St, Piqua, OH 45356
937-615-9968     937-615-9972

female pharmacist

Victoria Tebbe


Pharmacist
115 N College St, Piqua, OH 45356
937-773-3784    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.